| PUBCHEM ID |
91810672
|
| UNII |
GR82L4OOM4
|
| Preferred Term |
MIRABEGRON O-GLUCURONIDE
|
| CAS |
1365244-65-0
|
| INCHIKEY |
SKLQDOWMJNKLOR-JBWRIQTRSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
Nc1nc(CC(Nc2ccc(CCNC[C@H](c3ccccc3)O[C@H]([C@H]([C@@H]([C@H]3O)O)O)O[C@H]3C(O)=O)cc2)=O)cs1
|
| Total Surface Area |
416,36
|
| Relative PSA |
0,4035
|
| TPSA |
224,73
|
| cLogS |
-3,483
|
| MW |
572,637
|
| cLogP |
-1,3764
|
| H-Acceptors |
12
|
| H-Donors |
7
|
| Ro5 violations |
3
|
| Druglikeness |
4,4196
|
| DrugScore |
0,280902852254149
|
| Mutagenic |
high
|
| Tumorigenic |
none
|
| Reproductive Effective |
low
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB-
|
| Human Intestinal Absorption |
HIA-
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
-0,1595
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Non-substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,6089
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,3561
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,371
|
| Carcinogenicity (Three-class) |
Non-required
|
